Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss.
Guoju HongXiaoming HeYingshan ShenXiaojun ChenFang YangPeng YangFengxiang PangXiaorui HanWei HeQiu-Shi WeiPublished in: Stem cell research & therapy (2019)
Our study demonstrates that Chrysosplenetin improves osteoblastogenesis of hBMSCs and osteogenesis in estrogen deficiency-induced bone loss by regulating Wnt/β-catenin pathway.